A New Use for Dysport Could Be in the Works
Dysport, one of the three FDA-approved neuromodulators on the market, may one day have yet another approval under its belt. But, this one doesn’t have an aesthetic benefit, but rather more of a physical one.
More than one in eight active people suffer from painful knee conditions that respond positively to a mix of injections of botulinum toxin and physiotherapy. Recently, a trial was performed by researchers from Imperial College London and Fortius Clinic where 45 patients—specifically those who suffer from pain in the front and side of their knee from running and cycling—were treated with Dysport and therapy sessions.
You May Also Like: The One Thing No One Tells You About Losing Weight
The injections of Dysport, when done in the front hip muscle, relaxed the knee so that the buttock muscles were forced to be used more, in turn strengthening the muscles. After the full course of treatment was completed, 69 percent of the patients didn’t require additional medical treatment and had complete pain relief even five years later.
“This research is a really exciting step forward in the management of a very common cause of knee pain in athletes. Our results show that botulinum toxin can provide better and longer-lasting pain relief than the current conventional alternatives,” says Sam Church, consultant knee surgeon from Fortius Clinic.